Analysts make moves on NVCR, PLTK, S, TBLA
Stock bloggers weigh in on CYBR, ZIM
Big movers: ELWS
Elbit Systems disappoints with Q3 results
Paz expands its retail operation
Analysts Do What Analysts Do
NovoCure (NASDAQ:NVCR) — Rating boost to overweight from equalweight, by Wells Fargo; 12-month price target up to USD 89/share from USD 74.
Playtika (NASDAQ:PLTK) — 12-month price target down to USD 12 from USD 20 by Morgan Stanley; Rating to equalweight from overweight.
SentinelOne (NYSE:S) — 12-month price target down to USD 20 from USD 33 by Barclays; Remains equalweight.
Taboola.com (NASDAQ:TBLA) — 12-month price target down to USD 4.50 from USD 3.50 by Oppenheimer; Remains outperform.
Stock Bloggers Weigh In
CyberArk Software (NASDAQ:CYBR) was also covered on Seeking Alpha by Gary Bourgeault (ranked 1,823 out of 16,143 on TipRanks). He wrote that the shares of the Tel Aviv-based tech firm are still struggling to break out, as it's trading less than it was at the end of 2020. “Investors may be holding off to see if revenue growth is sustainable, and ultimately, profitable,” he added.
ZIM Integrated (NYSE:ZIM) was also covered on Seeking Alpha by Stone Fox Capital (ranked 324). “The stock isn't appealing, with the dividend disappearing and ZIM still trading above $22 despite the solid balance sheet,” they wrote. Adding “Analysts are now forecasting minimal EPS over the next few years, with some estimates already dipping into future losses.”
Big Movers of Note
Electreon Wireless (TLV:ELWS) up 15.2%, on higher than daily average volume.
Elbit Systems (NASDAQ:ESLT, TLV:ESLT) down 10.6% on earnings disappointment (see below).
Elbit Systems sees revenue drop in Q3
Israeli defense firm Elbit Systems (NASDAQ:ESLT, TLV:ESLT) posted USD 1.34 billion in revenues for Q3, down from USD 1.36 billion in the same period last year.
Elbit recorded a non-GAAP gross of USD 337.8 million, while non-GAAP operating income amounted to USD 84.3 million.
Elbit said its net income in Q3 amounted to USD 62.6 million, which was reduced by almost USD 22 million due to the net expenses associated with its stock price linked compensation plans.
At the end of September, the company's order backlog was at roughly USD 14.7 billion, with 75% of that amount from foreign orders. Elbit expects 40% of the orders to be carried out this year and in 2023.
Elbit’s US-traded shares closed down 10.6% following the earnings report, clawing back 1.2% in after hours trading.